Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJan 31, 2018Earth's Care Eczema LotionMicrobial Contamination of Non-Sterile Products.DLC Laboratories, Inc · D-0241-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0240-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0239-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0238-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0237-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0236-2018Class IITerminatedJan 31, 2018Ibuprofen TabletsCGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.Marksans Pharma Inc. · D-0235-2018Class IITerminatedJan 31, 2018Pravastatin Sodium TabletsPresence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.International Laboratories, Inc. · D-0234-2018Class IITerminatedJan 31, 2018Pravastatin Sodium TabletsPresence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.International Laboratories, Inc. · D-0233-2018Class IITerminatedJan 31, 2018Dry to Normal Skin Starter KitFailed Stability Specifications:stability failure at 12 months, long term RT conditions.Odan Laboratories Ltd · D-0232-2018Class IITerminatedJan 31, 2018Day Cream SPF15 Cr¿me de jour FPS 15Failed Stability Specifications:stability failure at 12 months, long term RT conditions.Odan Laboratories Ltd · D-0231-2018Class IIITerminatedJan 31, 2018bupPROPion HCL Extended-Release TabletsFailed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained...Mylan Pharmaceuticals Inc. · D-0230-2018Class IITerminatedJan 31, 2018DOXOrubicin Hydrochloride Liposome InjectionLack Of Assurance Of SterilitySun Pharmaceutical Industries, Inc. · D-0229-2018Class IITerminatedJan 24, 2018Divalproex Sodium Delayed Release Tablets USPCross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.Unichem Pharmaceuticals Usa Inc · D-0228-2018Class IITerminatedJan 24, 2018Rugby Aller-chlorMicrobial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contaminationPharmatech LLC · D-0227-2018Class IITerminatedJan 24, 2018Rugby Senexon Liquid Natural Vegetable StimulantMicrobial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contaminationPharmatech LLC · D-0226-2018Class IITerminatedJan 24, 2018Rugby Diocto SyrupMicrobial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contaminationPharmatech LLC · D-0225-2018Class IITerminatedJan 24, 2018Rugby Diocto LiquidMicrobial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contaminationPharmatech LLC · D-0224-2018Class IIITerminatedJan 24, 2018Simvastatin TabletsPresence of foreign substance: metallic razor blade was found in one bottle.Hetero Labs, Ltd. - Unit III · D-0223-2018Class IITerminatedJan 24, 2018Lovastatin Tablets USPFailed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.AVKARE Inc. · D-0222-2018Class IITerminatedJan 24, 2018Phenylephrine HCL 100 mcg per mLSuperpotent DrugPharmedium Services, LLC · D-0221-2018Class IITerminatedJan 24, 2018ePHEDrine Sulfate In 0.9% Sodium ChlorideSubpotent DrugPharmedium Services, LLC · D-0220-2018Class IIITerminatedJan 24, 2018Mefenamic Acid CapsulesPresence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid...Shionogi Inc. · D-0219-2018Class IITerminatedJan 24, 2018Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.Shiseido America Inc. · D-0218-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.Shiseido America Inc. · D-0217-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Discovery Set contains SPF 50+GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.Shiseido America Inc. · D-0216-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Universal Defense SPF 50+GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.Shiseido America Inc. · D-0215-2018Class IITerminatedJan 24, 2018bareMinerals Broad Spectrum SPF 50 Daily Prep LotionGMP Deviations: manufacturing of API material did not meet GMP and quality requirements.Shiseido America Inc. · D-0214-2018Class IITerminatedJan 17, 2018Docetaxel Injection USPDefective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is...Dr. Reddy's Laboratories, Inc. · D-0213-2018Class IITerminatedJan 17, 2018FOR EXPORT ONLY Atorvastatin calcium Film-Coated Tablets a) 80 mg SMT Tabs BulkMicrobial Contamination of Non-Sterile ProductsPfizer Manufacturing Deutschland GmbH · D-0212-2018Class IIITerminatedJan 17, 2018Gabapentin Oral SolutionCGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.Akorn Inc · D-0211-2018Class IITerminatedJan 17, 2018Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive ExpectorantMicrobial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepaciaWoodfield Pharmaceutical, LLC · D-0210-2018Class IITerminatedJan 17, 2018Valsartan TabletsFailed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.Prinston Pharmaceutical Inc · D-0209-2018Class IITerminatedJan 17, 2018Moexipril Hydrochloride and Hydrocholorothiazide Tablets USPFailed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability...Teva Pharmaceuticals USA · D-0208-2018Class IITerminatedJan 17, 20187-Keto DHEA 25mg CapsuleLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0207-2018Class IITerminatedJan 17, 20187-KetodehydroepiandrosteroneLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0206-2018Class IITerminatedJan 17, 2018Vitamin 10 B Lyophilized VialLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0205-2018Class IITerminatedJan 17, 2018Vitamin 9 A/B Lyophilized VialLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0204-2018Class IITerminatedJan 17, 2018Vitamin 9 Lyophilized VialLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0203-2018Class IITerminatedJan 17, 2018Cyclopentolate HCl/ Phenylephrine HCl/ Tropicamide/ Ketorolac 1%/ 10%/ 1%/ 0.5% Ophthalmic SolnLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0202-2018